Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications

被引:1645
作者
Berger, J
Reist, M
Mayer, JM
Felt, O
Peppas, NA
Gurny, R
机构
[1] Univ Geneva, Sch Pharm, CH-1211 Geneva 4, Switzerland
[2] Univ Lausanne, Sch Pharm, Lausanne, Switzerland
[3] Univ Texas, Dept Pharmaceut, Austin, TX USA
[4] Univ Texas, Dept Chem & Biomed Engn, Austin, TX USA
关键词
biomedical applications; chitosan; crosslinking; hydrogel; interaction; review; structure;
D O I
10.1016/s0939-6411(03)00161-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This review presents a critical analysis of covalently and ionically crosslinked chitosan hydrogels and related networks for medical or pharmaceutical applications. The structural basis of these hydrogels is discussed with reference to the specific chemical interactions, which dictate gel formation. The synthesis and chemistry of these hydrogels is discussed using specific pharmaceutical examples. Covalent crosslinking leads to formation of hydrogels with a permanent network structure, since irreversible chemical links are formed. This type of linkage allows absorption of water and/or bioactive compounds without dissolution and permits drug release by diffusion. pH-controlled drug delivery is made possible by the addition of another polymer. tonically crosslinked hydrogels are generally considered as biocompatible and well-tolerated. Their non-permanent network is formed by reversible links. tonically crosslinked chitosan hydrogels exhibit a higher swelling sensitivity to pH changes compared to covalently crosslinked chitosan hydrogels. This extends their potential application, since dissolution can occur in extreme acidic or basic pH conditions. (C) 2003 Published by Elsevier B.V.
引用
收藏
页码:19 / 34
页数:16
相关论文
共 155 条
  • [1] Preparation and some properties of immobilized Penicillium funiculosum 258 dextranase
    Abdel-Naby, MA
    Ismail, AMS
    Abdel-Fattah, AM
    Abdel-Fattah, AF
    [J]. PROCESS BIOCHEMISTRY, 1999, 34 (04) : 391 - 398
  • [2] Airoldi C, 2000, J APPL POLYM SCI, V77, P797, DOI 10.1002/(SICI)1097-4628(20000725)77:4<797::AID-APP12>3.0.CO
  • [3] 2-Z
  • [4] Aly AS, 1998, ANGEW MAKROMOL CHEM, V259, P13
  • [5] Rheological study of the chitosan glutaraldehyde chemical gel system
    Argüelles-Monal, W
    Goycoolea, FM
    Peniche, C
    Higuera-Ciapara, I
    [J]. POLYMER GELS AND NETWORKS, 1998, 6 (06) : 429 - 440
  • [6] Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures
    Ballantyne, B
    Jordan, SL
    [J]. JOURNAL OF APPLIED TOXICOLOGY, 2001, 21 (02) : 131 - 151
  • [7] A CRITICAL-REVIEW OF THE TOXICOLOGY OF GLUTARALDEHYDE
    BEAUCHAMP, RO
    STCLAIR, MBG
    FENNELL, TR
    CLARKE, DO
    MORGAN, KT
    KARI, FW
    [J]. CRITICAL REVIEWS IN TOXICOLOGY, 1992, 22 (3-4) : 143 - 174
  • [8] HEPARIN IMMOBILIZED CHITOSAN-POLYETHYLENEGLYCOL INTERPENETRATING NETWORK - ANTITHROMBOGENICITY
    BEENA, MS
    CHANDY, T
    SHARMA, CP
    [J]. ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1995, 23 (02): : 175 - 192
  • [9] BELMONTE MM, 1999, MINERVA STOMATOL, V48, P567
  • [10] BERGER J, UNPUB EUR J PHARM BI